Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022

SELL
$29.58 - $49.78 $17,925 - $30,166
-606 Reduced 83.36%
121 $4,000
Q3 2021

Nov 15, 2021

SELL
$41.92 - $58.18 $92,224 - $127,996
-2,200 Reduced 75.16%
727 $34,000
Q2 2021

Aug 16, 2021

SELL
$52.06 - $61.27 $203,971 - $240,055
-3,918 Reduced 57.24%
2,927 $161,000
Q1 2021

May 17, 2021

SELL
$44.23 - $57.5 $735,766 - $956,512
-16,635 Reduced 70.85%
6,845 $353,000
Q4 2020

Feb 17, 2021

BUY
$33.21 - $46.54 $779,770 - $1.09 Million
23,480 New
23,480 $1.02 Million
Q3 2020

Nov 12, 2020

SELL
$33.87 - $55.93 $1.11 Million - $1.84 Million
-32,886 Closed
0 $0
Q2 2020

Aug 14, 2020

SELL
$34.45 - $53.48 $1.41 Million - $2.18 Million
-40,800 Reduced 55.37%
32,886 $1.76 Million
Q1 2020

May 13, 2020

SELL
$31.52 - $53.81 $589,424 - $1.01 Million
-18,700 Reduced 20.24%
73,686 $2.61 Million
Q4 2019

Feb 14, 2020

BUY
$30.08 - $50.59 $1.55 Million - $2.61 Million
51,581 Added 126.41%
92,386 $4.41 Million
Q3 2019

Nov 12, 2019

BUY
$32.4 - $49.58 $616,863 - $943,953
19,039 Added 87.47%
40,805 $1.32 Million
Q2 2019

Aug 12, 2019

BUY
$46.17 - $68.1 $1 Million - $1.48 Million
21,766 New
21,766 $1.09 Million
Q1 2018

May 14, 2018

SELL
$59.83 - $86.53 $2.95 Million - $4.27 Million
-49,300 Closed
0 $0
Q4 2017

Feb 14, 2018

BUY
$52.12 - $72.33 $177,208 - $245,922
3,400 Added 7.41%
49,300 $2.82 Million
Q3 2017

Oct 30, 2017

SELL
$54.89 - $67.12 $120,758 - $147,664
-2,200 Reduced 4.57%
45,900 $3.06 Million
Q2 2017

Jan 31, 2018

BUY
N/A
17,600 Added 57.7%
48,100 $2.48 Million
Q1 2017

Jan 31, 2018

BUY
N/A
30,500
30,500 $1.78 Million

Others Institutions Holding AGIO

About AGIOS PHARMACEUTICALS, INC.


  • Ticker AGIO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 54,818,000
  • Market Cap $1.83B
  • Description
  • Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...
More about AGIO
Track This Portfolio

Track Canada Pension Plan Investment Board Portfolio

Follow Canada Pension Plan Investment Board and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Canada Pension Plan Investment Board, based on Form 13F filings with the SEC.

News

Stay updated on Canada Pension Plan Investment Board with notifications on news.